[
    {
        "length": 184,
        "text": "\nPART 1The Commissioner for Patient Safety\n\tEstablishment and core duties etc\n\t\tThe Secretary of State must appoint a Commissioner for Patient Safety(referred to in this Part as \u201cthe Commissioner\u201d) to exercise the functions setout in this Part in relation to England.\n\t\tThe Commissioner\u2019s core duties are to\u2014\n\t\t\tpromote the safety of patients with regard to the use of medicines andmedical devices, and\n\t\t\tpromote the importance of the views of patients and other members of thepublic in relation to the safety of medicines and medical devices.\n\t\tThe Commissioner is not to be regarded as the servant or agent of the Crownor as enjoying any status, immunity or privilege of the Crown.\n\t\tSchedule 1 makes further provision about the Commissioner."
    },
    {
        "length": 3713,
        "text": "\nPART 2Human medicines\n\tCHAPTER 1Regulations\n\t\tPower to make regulations about human medicines\n\t\t\tThe appropriate authority may by regulations make provision specified insections 3 to 7 amending or supplementing the law relating to human medicines.\n\t\t\tIn making regulations under subsection (1), the appropriate authority\u2019soverarching objective must be safeguarding public health.\n\t\t\tIn considering whether regulations under subsection (1) would contribute tothis objective, the appropriate authority must have regard to\u2014\n\t\t\t\tthe safety of human medicines;\n\t\t\t\tthe availability of human medicines;\n\t\t\t\tthe likelihood of the relevant part of the United Kingdom being seen as afavourable place in which to\u2014\n\t\t\t\tcarry out research relating to human medicines,\n\t\t\t\tconduct clinical trials, or\n\t\t\t\tmanufacture or supply human medicines.\n\t\t\tWhere regulations under subsection (1) may have an impact on the safety ofhuman medicines, the appropriate authority may make the regulations only ifthe authority considers that the benefits of doing so outweigh the risks.\n\t\t\tIn subsection (3)(c), \u201crelevant part of the United Kingdom\u201d means\u2014\n\t\t\t\tso far as the regulations relate to England and Wales and Scotland, thoseparts of the United Kingdom, and\n\t\t\t\tso far as the regulations relate to Northern Ireland, that part of theUnited Kingdom.\n\t\t\tIn this Part, \u201cappropriate authority\u201d means\u2014\n\t\t\t\tin relation to England and Wales and Scotland, the Secretary of State, and\n\t\t\t\tin relation to Northern Ireland\u2014\n\t\t\t\tthe Department of Health in Northern Ireland, or\n\t\t\t\tthe Department of Health in Northern Ireland and the Secretary of Stateacting jointly.\n\t\tManufacture, marketing and supply\n\t\t\tRegulations under section 2(1) may make provision about\u2014\n\t\t\t\tauthorisations to manufacture human medicines,\n\t\t\t\tauthorisations to import human medicines,\n\t\t\t\tauthorisations to distribute human medicines by way of wholesale dealing,\n\t\t\t\tmarketing authorisations,\n\t\t\t\tmanufacturing, importing or distributing active substances,\n\t\t\t\tbrokering in relation to human medicines,\n\t\t\t\tthe registration of the premises of pharmacy businesses,\n\t\t\t\tthe recording of information about the supply of human medicines,\n\t\t\t\tnotification and reporting requirements in relation to human medicines thathave been placed on the market,\n\t\t\t\tthe labelling and packaging of human medicines or the information that mustbe supplied with them or made available in relation to them,\n\t\t\t\tadvertising with regard to human medicines,\n\t\t\t\tthe registration of persons who supply or offer to supply human medicinesby means of the internet,\n\t\t\t\tthe requirements that must be met in relation to a prescription,\n\t\t\t\tprohibitions in the provisions mentioned in subsection (2), or\n\t\t\t\tthe use of tissues or cells (within the meanings given by regulation 5(1)of the Human Tissue (Quality and Safety for Human Application) Regulations2007 ([S.I. 2007/1523](/id/uksi/2007/1523?view=plain \"Go to item oflegislation\"))) in relation to human medicines.\n\t\t\tSubsection (1)(n) refers to the following provisions in the Human MedicinesRegulations 2012 ([S.I. 2012/1916](/id/uksi/2012/1916?view=plain \"Go to itemof legislation\"))\u2014\n\t\t\t\tregulation 214 and Schedule 13 (sale or supply of prescription onlymedicines),\n\t\t\t\tregulation 215 and Schedule 14 (prescribing and administration bysupplementary prescribers),\n\t\t\t\tregulation 220 (sale or supply of human medicines not subject to generalsale),\n\t\t\t\tregulation 221 and Schedule 15 (sale or supply of medicinal productssubject to general sale), and\n\t\t\t\tregulation 249 and Schedule 22 (restrictions on persons to be supplied withmedicinal products).\n\t\tFalsified medicines\n\t\t\tRegulations under section 2(1) may make provision about\u2014\n\t\t\t\tthe prevention of the supply of falsified human medicines, or\n\t\t\t\tthe use, retention and disclosure, for any purpose to do with humanmedicines, of information collected for the purpose of preventing the supplyof falsified human medicines.\n\t\t\tProvision made in reliance on subsection (1)(a) may (among other things)make provision\u2014\n\t\t\t\tfor human medicines that are subjects of a marketing authorisation to besupplied in packs that\u2014\n\t\t\t\tcarry unique identifiers associated with the products, and\n\t\t\t\tare protected with anti-tamper devices,\n\t\t\t\tfor checks to be carried out in relation to packs that have or should havesuch a unique identifier,\n\t\t\t\tabout the infrastructure, systems and processes required for the allocationand checking of unique identifiers, including provision about\u2014\n\t\t\t\twho is to set up the infrastructure, systems and processes,\n\t\t\t\twho is to maintain them, and\n\t\t\t\twho is to pay for them.\n\t\t\tIn making regulations in reliance on subsection (1), the appropriateauthority must have regard to the importance of ensuring that information isretained securely.\n\t\tClinical trials\n\t\t\tRegulations under section 2(1) may make provision\u2014\n\t\t\t\tcorresponding or similar to provision in the EU Clinical Trials Regulation,\n\t\t\t\tabout authorisations concerning clinical trials in the United Kingdom,including applications for an assessment of the ethics of a proposed clinicaltrial,\n\t\t\t\tabout notification and reporting requirements in relation to clinicaltrials,\n\t\t\t\tabout requirements that must be met before a clinical trial may be carriedout, or\n\t\t\t\trelating to the conduct of clinical trials.\n\t\t\tIn subsection (1)(a), \u201cEU Clinical Trials Regulation\u201d means [Regulation(EU) No 536/2014](/european/regulation/2014/0536?view=plain \"Go to item oflegislation\") of the European Parliament and of the Council of 16 April 2014on clinical trials on medicinal products for human use, and repealing[Directive 2001/20/EC](/european/directive/2001/0020?view=plain \"Go to item oflegislation\").\n\t\tFees, offences, powers of inspectors\n\t\t\tRegulations under section 2(1) may make provision\u2014\n\t\t\t\tabout the charging of fees in connection with the exercise of a functionconferred by a human medicines provision,\n\t\t\t\tcreating a criminal offence of failing to comply with a provision made inthe regulations, or\n\t\t\t\tapplying relevant powers of entry or other powers of inspectors with orwithout modification in relation to a prohibition or requirement in provisionmade in the regulations.\n\t\t\tRegulations under section 2(1) may not provide for an offence to bepunishable with a sentence of imprisonment of more than two years.\n\t\t\tIn subsection (1), \u201crelevant powers of entry or other powers of inspectors\u201dmeans powers of entry or powers of inspectors in\u2014\n\t\t\t\tPart 8 of the Medicines Act 1968;\n\t\t\t\tthe Medicines for Human Use (Clinical Trials) Regulations 2004 ([S.I.2004/1031](/id/uksi/2004/1031?view=plain \"Go to item of legislation\"));\n\t\t\t\tPart 16 of the Human Medicines Regulations 2012 ([S.I.2012/1916](/id/uksi/2012/1916?view=plain \"Go to item of legislation\")).\n\t\t\tIn this Part, \u201chuman medicines provision\u201d means a provision in\u2014\n\t\t\t\tregulations under section 2(1),\n\t\t\t\tthe Human Medicines Regulations 2012, or\n\t\t\t\tthe Medicines for Human Use (Clinical Trials) Regulations 2004.\n\t\tEmergencies \n\t\t\tRegulations under section 2(1) may make provision about the disapplicationof a human medicines provision in circumstances which give rise to a need toprotect the public from a risk of serious harm to health.\n\t\t\tRegulations made in reliance on subsection (1) may provide for thedisapplication to be subject to\u2014\n\t\t\t\tconditions set out in the regulations;\n\t\t\t\tconditions set out in a protocol published by the appropriate authority.\n\t\t\tWhere regulations made in reliance on subsection (1) provide that theappropriate authority may publish a protocol setting out conditions, theregulations must provide\u2014\n\t\t\t\tthat the appropriate authority may withdraw or amend the protocol, and\n\t\t\t\tthat the protocol is to have effect only for a period of time specified inthe protocol.\n\tCHAPTER 2International agreements: disclosure of information\n\t\tDisclosure of information in accordance with international agreements\n\t\t\tThis section applies to information which a relevant authority holds inconnection with human medicines.\n\t\t\tThe relevant authority may disclose information to a relevant personoutside the United Kingdom where\u2014\n\t\t\t\tthe disclosure is required for the purpose of giving effect to aninternational agreement or arrangement concerning the regulation of humanmedicines, and\n\t\t\t\tthe relevant authority considers that the disclosure is in the publicinterest.\n\t\t\tThe relevant authority may not disclose commercially sensitive informationin reliance on subsection (2) unless the relevant authority\u2014\n\t\t\t\tconsiders that it is necessary to do so for the purpose mentioned in thatsubsection, and\n\t\t\t\tis satisfied that the making of the disclosure is proportionate to what issought to be achieved by it.\n\t\t\tExcept as provided by subsections (5) and (6), the disclosure ofinformation in accordance with this section does not breach\u2014\n\t\t\t\tan obligation of confidence owed by the person making the disclosure, or\n\t\t\t\tany other restriction on the disclosure of the information (howeverimposed).\n\t\t\tNothing in this section authorises a disclosure of patient informationwithout the consent of the individual to whom that information relates.\n\t\t\tNothing in this section authorises a disclosure of information which\u2014\n\t\t\t\tcontravenes the data protection legislation (but in determining whether adisclosure would do so, take into account the powers conferred by thissection), or\n\t\t\t\tis prohibited by any of Parts 1 to 7 or Chapter 1 of Part 9 of theInvestigatory Powers Act 2016.\n\t\t\tThis section does not limit the circumstances in which information may bedisclosed under any other enactment or rule of law.\n\t\t\tIn this section\u2014\n\t\t\t\t  * \u201ccommercially sensitive information\u201d means commercial information whose disclosure the relevant authority thinks might significantly harm the legitimate business interests of the undertaking to which it relates; \n\t\t\t\t  * \u201cdata protection legislation\u201d has the meaning given by section 3(9) of the Data Protection Act 2018; \n\t\t\t\t  * \u201cpatient information\u201d means information (however recorded) which\u2014 \n\t\t\t\trelates to\u2014\n\t\t\t\tthe physical or mental health or condition of an individual,\n\t\t\t\tthe diagnosis of an individual\u2019s condition, or\n\t\t\t\tan individual\u2019s care or treatment,\n\t\t\t\t\tor is (to any extent) derived directly or indirectly from information relatingto any of those matters, and\n\t\t\t\tidentifies the individual or enables the individual to be identified (whetherby itself or in combination with other information);\n\t\t\t\t\t  * \u201crelevant authority\u201d means\u2014 \n\t\t\t\tthe Secretary of State, or\n\t\t\t\tthe Department of Health in Northern Ireland;\n\t\t\t\t\t  * \u201crelevant person\u201d means\u2014 \n\t\t\t\tthe government of a country or territory outside the United Kingdom;\n\t\t\t\ta person who exercises functions on behalf of such a government;\n\t\t\t\tany other person who exercises functions or provides services relating tohuman medicines in a country or territory outside the United Kingdom;\n\t\t\t\tan international organisation that exercises functions or provides servicesrelating to human medicines.\n\tCHAPTER 3Interpretation\n\t\tInterpretation of Part 2\n\t\t\tIn this Part\u2014\n\t\t\t  * \u201cactive substance\u201d has the meaning given by regulation 8 of the Human Medicines Regulations 2012 ([S.I. 2012/1916](/id/uksi/2012/1916?view=plain \"Go to item of legislation\")); \n\t\t\t  * \u201cappropriate authority\u201d has the meaning given by section 2(6); \n\t\t\t  * \u201cclinical trial\u201d has the meaning given by regulation 2(1) of the Medicines for Human Use (Clinical Trials) Regulations 2004 ([S.I. 2004/1031](/id/uksi/2004/1031?view=plain \"Go to item of legislation\")); \n\t\t\t  * \u201cEU Clinical Trials Regulation\u201d has the meaning given by section 5(2); \n\t\t\t  * \u201cfalsified human medicine\u201d means a falsified medicinal product within the meaning given by regulation 8 of the Human Medicines Regulations 2012; \n\t\t\t  * \u201chuman medicine\u201d means a medicinal product within the meaning given by regulation 2 of the Human Medicines Regulations 2012; \n\t\t\t  * \u201chuman medicines provision\u201d has the meaning given by section 6(4); \n\t\t\t  * \u201claw relating to human medicines\u201d means\u2014 \n\t\t\t\tsections 10 and 15, and Part 4, and section 131 of the Medicines Act 1968(which make provision relating to pharmacies),\n\t\t\t\tthe Human Medicines Regulations 2012,\n\t\t\t\tthe Medicines for Human Use (Clinical Trials) Regulations 2004, and\n\t\t\t\tthe Medicines (Products for Human Use) (Fees) Regulations 2016 ([S.I.2016/190](/id/uksi/2016/190?view=plain \"Go to item of legislation\"));\n\t\t\t\t\t  * \u201cmanufacture\u201d includes assembly; \n\t\t\t\t\t  * \u201cmarketing authorisation\u201d means an authorisation to market a human medicine in the United Kingdom; \n\t\t\t\t\t  * \u201cpharmacy business\u201d means a business (other than a professional practice carried on by a doctor or dentist) which consists of or includes the sale of medicinal products that are not subject to general sale; \n\t\t\t\t\t  * \u201csupplying\u201d includes administering within the meaning given by regulation 8 of the Human Medicines Regulations 2012 (and related expressions are to be read accordingly). "
    },
    {
        "length": 2592,
        "text": "\nPART 3Veterinary medicines\n\tCHAPTER 1Regulations\n\t\tPower to make regulations about veterinary medicines\n\t\t\tThe appropriate authority may by regulations make provision specified insections 11 and 12 amending or supplementing the Veterinary MedicinesRegulations 2013 ([S.I. 2013/2033](/id/uksi/2013/2033?view=plain \"Go to itemof legislation\")).\n\t\t\tIn making regulations under subsection (1), the appropriate authority\u2019soverarching objective must be to promote one or more of the following\u2014\n\t\t\t\tthe health and welfare of animals;\n\t\t\t\tthe health and safety of the public;\n\t\t\t\tthe protection of the environment.\n\t\t\tIn considering whether regulations under subsection (1) would contribute tothis objective, the appropriate authority must have regard to\u2014\n\t\t\t\tthe safety of veterinary medicines;\n\t\t\t\tthe availability of veterinary medicines;\n\t\t\t\tthe likelihood of the relevant part of the United Kingdom being seen as afavourable place in which to\u2014\n\t\t\t\tdevelop veterinary medicines, or\n\t\t\t\tmanufacture or supply veterinary medicines.\n\t\t\tWhere regulations under subsection (1) may have an impact on the safety ofveterinary medicines, the appropriate authority may make the regulations onlyif the authority considers that the benefits of doing so outweigh the risks.\n\t\t\tIn subsection (3)(c), \u201crelevant part of the United Kingdom\u201d means\u2014\n\t\t\t\tso far as the regulations relate to England and Wales and Scotland, thoseparts of the United Kingdom, and\n\t\t\t\tso far as the regulations relate to Northern Ireland, that part of theUnited Kingdom.\n\t\t\tIn this Part, \u201cappropriate authority\u201d means\u2014\n\t\t\t\tin relation to England and Wales and Scotland, the Secretary of State, and\n\t\t\t\tin relation to Northern Ireland\u2014\n\t\t\t\tthe Department of Agriculture, Environment and Rural Affairs in NorthernIreland, or\n\t\t\t\tthe Department of Agriculture, Environment and Rural Affairs in NorthernIreland and the Secretary of State acting jointly.\n\t\tManufacture, marketing, supply and field trials\n\t\t\tRegulations under section 10(1) may make provision about\u2014\n\t\t\t\tauthorisations to manufacture veterinary medicines,\n\t\t\t\tauthorisations to import veterinary medicines,\n\t\t\t\tauthorisations to distribute veterinary medicines by way of wholesaledealing,\n\t\t\t\tmarketing authorisations,\n\t\t\t\tmarketing, importing or distributing active substances,\n\t\t\t\tthe categories of person who may supply veterinary medicines,\n\t\t\t\trequirements that must be met in relation to the supply of veterinarymedicines,\n\t\t\t\tthe registration of persons who supply or offer to supply veterinarymedicines by means of the internet,\n\t\t\t\tthe circumstances in which veterinary medicines may be administered,\n\t\t\t\tnotification and reporting requirements in relation to veterinary medicines(or things purporting to be veterinary medicines) that have been placed on themarket,\n\t\t\t\tthe labelling and packaging of veterinary medicines or the information thatmust be supplied with them or made available in relation to them,\n\t\t\t\tadvertising with regard to veterinary medicines, or\n\t\t\t\tanimal test certificates granted under the Veterinary Medicines Regulations2013 ([S.I. 2013/2033](/id/uksi/2013/2033?view=plain \"Go to item oflegislation\")) for research purposes.\n\t\t\tRegulations under section 10(1) may make provision corresponding or similarto provision in the following EU Regulations\u2014\n\t\t\t\t[Regulation (EU) 2019/4](/european/regulation/2019/0004?view=plain \"Go toitem of legislation\") of the European Parliament and of the Council of 11December 2018 on the manufacture, placing on the market and use of medicatedfeed, amending Regulation [(EC) No183/2005](/european/regulation/2005/0183?view=plain \"Go to item oflegislation\") of the European Parliament and of the Council and repealingCouncil Directive [90/167/EEC](/european/directive/1990/0167?view=plain \"Go toitem of legislation\");\n\t\t\t\t[Regulation (EU) 2019/6](/european/regulation/2019/0006?view=plain \"Go toitem of legislation\") of the European Parliament and of the Council of 11December 2018 on veterinary medicinal products and repealing [Directive2001/82/EC](/european/directive/2001/0082?view=plain \"Go to item oflegislation\").\n\t\tFees, offences, powers of inspectors, costs\n\t\t\tRegulations under section 10(1) may make provision\u2014\n\t\t\t\tabout the charging of fees in connection with the exercise of a functionconferred by a veterinary medicines provision,\n\t\t\t\tcreating a criminal offence of failing to comply with a provision made inthe regulations,\n\t\t\t\tapplying powers of entry or other powers of an inspector in the VeterinaryMedicines Regulations 2013 ([S.I. 2013/2033](/id/uksi/2013/2033?view=plain \"Goto item of legislation\")) with or without modification in relation to aprohibition or requirement in provision made in regulations under section10(1), or\n\t\t\t\tabout the recovery of costs incurred in the administration of improvementnotices or seizure notices under the Veterinary Medicines Regulations 2013(see regulations 38 and 41).\n\t\t\tRegulations under section 10(1) may not provide for an offence to bepunishable with a sentence of imprisonment of more than two years.\n\t\t\tRegulations applying powers of entry in reliance on subsection (1)(c) maynot confer a power of entry in respect of premises used wholly or mainly as aprivate dwelling unless those premises, or any part of them, are approved,registered or authorised for the sale or supply of veterinary medicines undera veterinary medicines provision.\n\t\t\tIn this section, \u201cveterinary medicines provision\u201d means a provision in\u2014\n\t\t\t\tregulations under section 10(1), or\n\t\t\t\tthe Veterinary Medicines Regulations 2013.\n\tCHAPTER 2International agreements: disclosure of information\n\t\tDisclosure of information in accordance with international agreements\n\t\t\tThis section applies to information which a relevant authority holds inconnection with veterinary medicines.\n\t\t\tThe relevant authority may disclose information to a relevant personoutside the United Kingdom where\u2014\n\t\t\t\tthe disclosure is required for the purpose of giving effect to aninternational agreement or arrangement concerning the regulation of veterinarymedicines, and\n\t\t\t\tthe relevant authority considers that the disclosure is in the publicinterest.\n\t\t\tThe relevant authority may not disclose commercially sensitive informationin reliance on subsection (2) unless the relevant authority\u2014\n\t\t\t\tconsiders that it is necessary to do so for the purpose mentioned in thatsubsection, and\n\t\t\t\tis satisfied that the making of the disclosure is proportionate to what issought to be achieved by it.\n\t\t\tExcept as provided by subsection (5), the disclosure of information inaccordance with this section does not breach\u2014\n\t\t\t\tan obligation of confidence owed by the person making the disclosure, or\n\t\t\t\tany other restriction on the disclosure of the information (howeverimposed).\n\t\t\tNothing in this section authorises a disclosure of information which\u2014\n\t\t\t\tcontravenes the data protection legislation (but in determining whether adisclosure would do so, take into account the powers conferred by thissection), or\n\t\t\t\tis prohibited by any of Parts 1 to 7 or Chapter 1 of Part 9 of theInvestigatory Powers Act 2016.\n\t\t\tThis section does not limit the circumstances in which information may bedisclosed under any other enactment or rule of law.\n\t\t\tIn this section\u2014\n\t\t\t\t  * \u201ccommercially sensitive information\u201d means commercial information whose disclosure the relevant authority thinks might significantly harm the legitimate business interests of the undertaking to which it relates; \n\t\t\t\t  * \u201cdata protection legislation\u201d has the meaning given by section 3(9) of the Data Protection Act 2018; \n\t\t\t\t  * \u201crelevant authority\u201d means\u2014 \n\t\t\t\tthe Secretary of State, or\n\t\t\t\tthe Department of Agriculture, Environment and Rural Affairs in NorthernIreland;\n\t\t\t\t\t  * \u201crelevant person\u201d means\u2014 \n\t\t\t\tthe government of a country or territory outside the United Kingdom;\n\t\t\t\ta person who exercises functions on behalf of such a government;\n\t\t\t\tany other person who exercises functions or provides services relating toveterinary medicines in a country or territory outside the United Kingdom;\n\t\t\t\tan international organisation that exercises functions or provides servicesrelating to veterinary medicines.\n\tCHAPTER 3Interpretation etc\n\t\tInterpretation of Part 3 and supplementary provision\n\t\t\tIn this Part\u2014\n\t\t\t\t  * \u201cactive substance\u201d means any substance or mixture of substances intended to be used in the manufacture of a veterinary medicine that, when used in its production, becomes an active ingredient of that medicine; \n\t\t\t\t  * \u201cappropriate authority\u201d has the meaning given by section 10(6); \n\t\t\t\t  * \u201cmanufacture\u201d includes assembly; \n\t\t\t\t  * \u201cmarketing authorisation\u201d means an authorisation to market a veterinary medicine in the United Kingdom; \n\t\t\t\t  * \u201cveterinary medicine\u201d means a veterinary medicinal product within the meaning given by regulation 2 of the Veterinary Medicines Regulations 2013 ([S.I. 2013/2033](/id/uksi/2013/2033?view=plain \"Go to item of legislation\")). \n\t\t\tIn the Animals (Scientific Procedures) Act 1986, in section 2 (regulatedprocedures), in subsection (8)(d), after \u201cthe Veterinary Medicines Regulations2011\u201d insert \u201cor the Veterinary Medicines Regulations 2013\u201d."
    },
    {
        "length": 1359,
        "text": "\nCHAPTER 1Regulations: general\n\tPower to make regulations about medical devices\n\t\tThe Secretary of State may by regulations make provision specified insections 16 to 18 amending or supplementing the Medical Devices Regulations2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain \"Go to item oflegislation\")).\n\t\tIn making regulations under subsection (1), the Secretary of State\u2019soverarching objective must be safeguarding public health.\n\t\tIn considering whether regulations under subsection (1) would contribute tothis objective, the Secretary of State must have regard to\u2014\n\t\t\tthe safety of medical devices;\n\t\t\tthe availability of medical devices;\n\t\t\tthe likelihood of the United Kingdom being seen as a favourable place inwhich to\u2014\n\t\t\tcarry out research relating to medical devices,\n\t\t\tdevelop medical devices, or\n\t\t\tmanufacture or supply medical devices.\n\t\tWhere regulations under subsection (1) may have an impact on the safety ofmedical devices, the Secretary of State may make the regulations only if theSecretary of State considers that the benefits of doing so outweigh the risks.\n\tManufacture, marketing and supply\n\t\tRegulations under section 15(1) may make provision about\u2014\n\t\t\trequirements that must be met in relation to medical devices in order forthem to be marketed, put into service or otherwise supplied (\u201crelevantrequirements\u201d), including\u2014\n\t\t\trequirements in terms of design, manufacture, composition or othercharacteristics of the devices, or\n\t\t\trequirements imposed on persons involved in marketing or supplying thedevices,\n\t\t\tassessments of whether relevant requirements are met in relation to medicaldevices,\n\t\t\twho may carry out such assessments, including provision about theappointment of one or more persons (whether or not established in the UnitedKingdom) who meet criteria set out in the regulations\u2014\n\t\t\tto assess whether relevant requirements are met, and\n\t\t\tif appropriate, to confirm that they are,\n\t\t\ttreating confirmation that relevant requirements are met given by one ormore persons who are not appointed under provision made in reliance onparagraph (c) in the same way as confirmation given by a person who is soappointed,\n\t\t\tthe making of declarations confirming that relevant requirements are met,\n\t\t\trequirements that medical devices carry evidence that relevant requirementsare met, including evidence that confirmation has been given as mentioned inparagraph (c) or (d),\n\t\t\tthe packaging of medical devices, and information, labelling orinstructions to be supplied on, with or in relation to them,\n\t\t\tone or more registers of medical devices, their manufacturers or theirsuppliers, including provision\u2014\n\t\t\tconferring functions relating to establishing and maintaining a register,\n\t\t\trequiring information in relation to a medical device to be entered in aregister, and\n\t\t\tpermitting or requiring some or all of the information entered in aregister to be made publicly available,\n\t\t\tinvestigations into or evaluations of the safety or performance, includingthe clinical effectiveness, of medical devices, or\n\t\t\tsurveillance of the market in medical devices.\n\t\tProvision made in reliance on subsection (1)(a) may (among other things)identify relevant requirements by reference to international agreements orstandards relating to the marketing or supply of medical devices, includingagreements or standards as they have effect from time to time.\n\tFees, information, offences\n\t\tRegulations under section 15(1) may make provision\u2014\n\t\t\tabout the charging of fees in connection with the exercise of a functionconferred by a medical devices provision, including the charging of fees by aperson appointed under provision made in reliance on section 16(1)(c),\n\t\t\tabout the recording of information regarding the safety and performance,including the clinical effectiveness, of medical devices, including the extentto which relevant requirements that apply in relation to the devices are met,\n\t\t\tpermitting or requiring such information to be disclosed to the Secretaryof State or to a person appointed under provision made in reliance on section16(1)(c), or\n\t\t\tamending the Schedule to the Medical Devices Regulations 2002 ([S.I.2002/618](/id/uksi/2002/618?view=plain \"Go to item of legislation\")) insertedby Schedule 3 to this Act (list of regulations breach of which is an offenceunder regulation 60A).\n\t\tIn this Part, \u201cmedical devices provision\u201d means a provision in\u2014\n\t\t\tregulations under section 15(1), or\n\t\t\tthe Medical Devices Regulations 2002.\n\tEmergencies \n\t\tRegulations under section 15(1) may make provision about the disapplicationof a medical devices provision in circumstances which give rise to a need toprotect the public from a risk of serious harm to health.\n\t\tRegulations made in reliance on subsection (1) may provide for thedisapplication to be subject to\u2014\n\t\t\tconditions set out in the regulations;\n\t\t\tconditions set out in a protocol published by the Secretary of State.\n\t\tWhere regulations made in reliance on subsection (1) provide that theSecretary of State may publish a protocol setting out conditions, theregulations must provide\u2014\n\t\t\tthat the Secretary of State may withdraw or amend the protocol, and\n\t\t\tthat the protocol is to have effect only for a period of time specified inthe protocol."
    },
    {
        "length": 1130,
        "text": "\nCHAPTER 2Regulations: information systems, advisory committee\n\tInformation systems\n\t\tThe Secretary of State may by regulations make provision about theestablishment and operation by the Health and Social Care Information Centre(\u201cthe Information Centre\u201d) of one or more information systems for purposesrelating to\u2014\n\t\t\tthe safety and performance, including the clinical effectiveness, ofmedical devices that are placed on the market;\n\t\t\tthe safety of individuals who receive or are treated with a medical device,or into whom a medical device is implanted;\n\t\t\tthe improvement of medical device safety and performance through advancesin technology.\n\t\tThe regulations may (among other things) make provision\u2014\n\t\t\tspecifying descriptions of information in relation to medical devices whichmay or must be entered or retained in an information system established undersubsection (1);\n\t\t\trequiring information to be provided to the Information Centre for thepurposes of its functions under the regulations;\n\t\t\tabout the use or disclosure of information contained in an informationsystem established under subsection (1);\n\t\t\trequiring the Information Centre to have regard to specified matters inexercising its functions under the regulations.\n\t\tThe provision mentioned in subsection (2)(b) may include provision\u2014\n\t\t\trequiring specified persons or descriptions of persons to whom subsection(4) applies to provide information of a specified description to theInformation Centre;\n\t\t\tabout the manner in which, and the time at which, those persons mustprovide that information;\n\t\t\tenabling the Information Centre to require specified persons ordescriptions of persons to whom subsection (4) applies to provide to it in amanner, and at a time, determined by the Information Centre\u2014\n\t\t\tinformation of a specified description;\n\t\t\tinformation for specified purposes;\n\t\t\tany other information that the Information Centre considers it necessaryor expedient to have for the purposes of its functions under the regulations;\n\t\t\tabout any procedural steps the Information Centre must follow in requiringa person to provide information to it;\n\t\t\trequiring specified persons or descriptions of persons to whom subsection(4) applies to record or retain information which they are, or may be,required to provide to the Information Centre under the regulations;\n\t\t\tin relation to the enforcement of any requirement imposed by or under theregulations.\n\t\tThis subsection applies to any person who provides services, or exercisesany powers or duties, relating to medical devices.\n\t\tThe descriptions of information specified in the provision mentioned insubsections (2)(a), (3)(a) and (3)(c)(i) may include\u2014\n\t\t\tunique identifiers associated with medical devices;\n\t\t\tinformation in relation to individuals mentioned in subsection (1)(b);\n\t\t\tinformation about any procedure carried out in relation to a medical device(including information about any person involved in carrying out theprocedure).\n\t\tThe provision mentioned in subsection (2)(c) may include provision about\u2014\n\t\t\tthe analysis by the Information Centre of information contained in aninformation system (whether alone or in combination with other information)for the purposes mentioned in subsection (1) or for other purposes;\n\t\t\tthe publication by the Information Centre of information contained in aninformation system;\n\t\t\tthe disclosure (other than by way of publication) of information containedin an information system to specified persons or descriptions of persons, orfor specified purposes;\n\t\t\tthe use or further disclosure by any person of information disclosed tothem under the regulations.\n\t\tThe provision mentioned in subsection (3)(f) may include provision applyingany provision of Chapter 3 of this Part (enforcement), with or withoutmodifications, in relation to a requirement imposed by or under theregulations.\n\t\tIn this section, \u201cspecified\u201d means specified in regulations undersubsection (1).\n\tAdvisory committee\n\t\tThe Secretary of State may by regulations establish, and make otherprovision about, a committee to advise the Secretary of State on such mattersrelating to medical devices as the regulations may specify.\n\t\tThe regulations may (among other things) make provision about\u2014\n\t\t\tthe membership of the committee;\n\t\t\tthe establishment by the committee of sub-committees;\n\t\t\tmatters to which the committee may, or must, have regard;\n\t\t\tcooperation between the committee and the Commission on Human Medicines,and other bodies with expertise in relation to medical devices.\n\t\tThe provision mentioned in subsection (2)(a) may include\u2014\n\t\t\tprovision about the number of members, their appointment, and thecircumstances in which a person ceases to be a member;\n\t\t\trequirements as to the independence of members from the Secretary of State;\n\t\t\tprovision about the payment of remuneration and allowances to members."
    },
    {
        "length": 2323,
        "text": "\nEnforcement notices\n\tCompliance notices\n\t\tThis section applies where the enforcement authority has reasonable groundsto suspect that a person involved in marketing or supplying a medical deviceis not complying with a medical devices provision.\n\t\tThe enforcement authority may serve a notice (\u201ca compliance notice\u201d) on theperson\u2014\n\t\t\tidentifying the medical devices provision with which the person issuspected not to be complying,\n\t\t\tsetting out the enforcement authority\u2019s grounds for suspecting that theperson is not complying with the provision,\n\t\t\trequiring the person to comply with the provision within a specifiedperiod,\n\t\t\trequiring the person within a specified period to provide evidence to thesatisfaction of the enforcement authority that the person is complying withthe provision, and\n\t\t\trequiring the person within a specified period to take any other measuresthat may be specified in order to comply with the provision.\n\t\tA period specified in reliance on subsection (2)(c), (d) or (e) must be aperiod of at least 28 days beginning with the day on which the notice isserved.\n\t\tThe enforcement authority may vary or revoke a compliance notice.\n\t\tWhere the person mentioned in subsection (1) is a manufacturer, a noticeunder subsection (2) may be served on the manufacturer or on another personwho has been designated by the manufacturer to act as the manufacturer\u2019srepresentative (or both).\n\t\tIn this section, \u201cspecified\u201d means specified in the compliance notice.\n\tSuspension notices\n\t\tThis section applies where the enforcement authority considers that it maybe necessary to restrict the availability of a medical device in order toprotect health or safety.\n\t\tThe enforcement authority may serve on a person a notice (\u201ca suspensionnotice\u201d) prohibiting the person from doing the following except with theconsent of the enforcement authority\u2014\n\t\t\tsupplying the medical device;\n\t\t\toffering to supply it;\n\t\t\tagreeing to supply it;\n\t\t\texposing it for supply;\n\t\t\tpossessing it for supply.\n\t\tA suspension notice must\u2014\n\t\t\tset out the enforcement authority\u2019s grounds for considering that it may benecessary to restrict the availability of the medical device to which thenotice relates, and\n\t\t\tspecify the period for which the notice has effect.\n\t\tThe period may not end more than 6 months after the day on which thesuspension notice is served.\n\t\tThe enforcement authority may\u2014\n\t\t\treduce the period for which a suspension notice has effect, or\n\t\t\trevoke a suspension notice.\n\tSafety notices\n\t\tThe enforcement authority may serve on a person a notice (\u201ca safetynotice\u201d) imposing on the person prohibitions or requirements that theenforcement authority considers necessary to restrict the availability of amedical device in order to protect health or safety.\n\t\tThe prohibitions that may be imposed include prohibitions on doing any ofthe following except with the consent of the enforcement authority\u2014\n\t\t\tsupplying the medical device;\n\t\t\toffering to supply it;\n\t\t\tagreeing to supply it;\n\t\t\texposing it for supply;\n\t\t\tpossessing it for supply.\n\t\tThe requirements that may be imposed include requirements to\u2014\n\t\t\tpublish, at the person\u2019s expense, one or more warnings, in such form andmanner and on such occasions as may be specified in the notice, about amedical device which the person supplies or has supplied;\n\t\t\torganise or cooperate with the enforcement authority in organising in suchmanner as may be specified in the notice, so far as reasonably practicable,the recall of the device to the person or to any other person identified inthe notice.\n\t\tBut a requirement to organise or cooperate in the recall of a device may beimposed on a person in reliance on subsection (3)(b) only if the enforcementauthority is satisfied that no alternative requirement would sufficientlyprotect health or safety as mentioned in subsection (1).\n\t\tA safety notice must set out the grounds on which the enforcement authorityconsiders it necessary to restrict the availability of the medical device towhich the notice relates.\n\t\tThe enforcement authority may vary or revoke a safety notice.\n\t\tSubject to subsection (8), the enforcement authority may not serve a safetynotice on a person or vary a safety notice unless the enforcement authorityhas given the person a reasonable opportunity to make representations aboutthe need for, and the contents of, the proposed safety notice or, as the casemay be, proposed variation.\n\t\tSubsection (7) does not apply where the enforcement authority considersthat there is an urgent need to make the proposed safety notice or variationin order to restrict the availability of the medical device to which theproposed safety notice or variation relates.\n\tInformation notices\n\t\tThis section applies where the enforcement authority considers that aperson has information which the enforcement authority needs for the purposeof deciding whether to\u2014\n\t\t\tserve or revoke a compliance notice,\n\t\t\tserve or revoke a suspension notice, or\n\t\t\tserve, vary or revoke a safety notice.\n\t\tThe enforcement authority may serve on the person a notice (an \u201cinformationnotice\u201d) requiring the person\u2014\n\t\t\tto disclose to the enforcement authority information specified in thenotice, within a period specified in the notice, or\n\t\t\tto produce records specified in the notice at a time and place specified inthe notice, and to permit a person appointed by the enforcement authority totake copies of the records at that time and place.\n\t\tA period specified in reliance on subsection (2)(a) must be a period of atleast 28 days beginning with the day on which the notice is served.\n\t\tA time specified in reliance on subsection (2)(b) must be at least 28 daysafter the notice is served.\n\t\tThe enforcement authority may vary or revoke an information notice.\n\tApplications to set notices aside etc\n\t\tA person affected by a compliance, suspension or safety notice may apply tothe appropriate lower court (see section 42)\u2014\n\t\t\tto set the notice aside, or\n\t\t\tto vary it.\n\t\tA person on whom an information notice has been served may apply to theappropriate lower court\u2014\n\t\t\tto set the notice aside, or\n\t\t\tto vary it as mentioned in subsection (8).\n\t\tAn application under subsection (1) or (2) must be made within the periodof 28 days beginning with the day on which the notice to which it relates is\u2014\n\t\t\tserved, or\n\t\t\tvaried by the enforcement authority.\n\t\tThe appropriate lower court may set aside a compliance, suspension, safetyor information notice only if satisfied\u2014\n\t\t\tin respect of a compliance notice, that the person on whom the notice wasserved is complying with each medical devices provision with which the personwas suspected not to be complying,\n\t\t\tin respect of a suspension notice, that the notice is not necessary toprotect health or safety,\n\t\t\tin respect of a safety notice, that the prohibitions or requirements in thenotice are not necessary to protect health or safety, or\n\t\t\tin respect of an information notice, that the person on whom it has beenserved does not have the information or records specified in the notice.\n\t\tThe appropriate lower court may vary a compliance notice so that it doesnot apply in relation to a medical devices provision specified in the noticeif satisfied that the person on whom the notice was served is complying withthat provision.\n\t\tThe appropriate lower court may vary a suspension notice by reducing theperiod for which it is to have effect if satisfied that the period for whichit would otherwise have had effect was too long.\n\t\tThe appropriate lower court may vary a safety notice by removing aprohibition or requirement if satisfied that the prohibition or requirement isnot necessary to protect health or safety.\n\t\tThe appropriate lower court may vary an information notice so that it doesnot apply in relation to some of the information or records specified in thenotice if satisfied that the person on whom it was served does not have thatinformation or those records.\n\t\tAn order of the appropriate lower court varying or setting aside acompliance, suspension, safety or information notice may contain provisiondelaying the coming into force of the order pending the making anddetermination of an appeal under section 27.\n\tCompensation \n\t\tA person affected by a compliance, suspension or safety notice which theappropriate lower court varies or sets aside may apply to the appropriatelower court for an order requiring the enforcement authority to paycompensation in respect of loss or damage caused by reason of the notice.\n\t\tAn application under subsection (1) may be made at the same time as anapplication under section 25(1).\n\tFurther appeals\n\t\tA person aggrieved by a decision of the appropriate lower court on anapplication under section 25(1) or (2) or section 26(1) may appeal againstthat decision to the appropriate appeals court (see section 42).\n\t\tAn appeal under subsection (1) must be made before the end of the period of28 days beginning with the day on which the decision to which it relates ismade.\n\t\tThe appropriate appeals court may make any order the court thinksappropriate."
    },
    {
        "length": 903,
        "text": "\nOffences\n\tOffences \n\t\tA person commits an offence if the person breaches\u2014\n\t\t\ta compliance notice,\n\t\t\ta suspension notice,\n\t\t\ta safety notice, or\n\t\t\tan information notice.\n\t\tA person guilty of an offence under subsection (1) is liable\u2014\n\t\t\ton summary conviction in England and Wales, to imprisonment for a term notexceeding 51 weeks, to a fine or to both;\n\t\t\ton summary conviction in Scotland or Northern Ireland, to imprisonment fora term not exceeding 6 months, to a fine not exceeding level 5 on the standardscale or to both.\n\t\tIn relation to an offence committed before the coming into force of section281(5) of the Criminal Justice Act 2003, the reference in subsection (2)(a) to51 weeks is to be read as a reference to 6 months.\n\tDefence of due diligence\n\t\tIt is a defence for a person charged with an offence under section 28(1) toshow that the person took all reasonable steps and exercised all due diligenceto avoid commission of the offence.\n\t\tIf in any proceedings for such an offence the defence provided bysubsection (1) involves an allegation that the commission of the offence wasdue to\u2014\n\t\t\tan act or default of another person, or\n\t\t\treliance on information given by another person,\n\t\t\t\tthe defendant is not, without leave of the court, entitled to rely on thatdefence unless the requirement in subsection (3) is satisfied.\n\t\tThe requirement is that at least 7 clear days before the hearing of theproceedings the defendant has served on the prosecutor a notice giving suchinformation identifying or assisting in the identification of that otherperson as was then in the defendant\u2019s possession.\n\t\tA defendant is not entitled to rely on the defence provided by subsection(1) by reason of the defendant\u2019s reliance on information supplied by anotherperson unless the defendant shows that it was reasonable in all thecircumstances to rely on the information, having regard in particular to\u2014\n\t\t\tthe steps which the defendant took or might reasonably have taken to verifythe information, and\n\t\t\twhether the defendant had any reason to disbelieve the information.\n\t\tIn the application of this section to Scotland\u2014\n\t\t\treferences to the defendant are to be read as references to the accused,and\n\t\t\tthe reference in subsection (3) to \u201cthe hearing of the proceedings\u201d is tobe read as a reference to \u201cthe trial diet\u201d.\n\tOffences by bodies corporate\n\t\tWhere an offence under section 28 committed by a body corporate or aScottish partnership is proved to have been committed with the consent orconnivance of, or to be attributable to any neglect on the part of, anofficer, the officer (as well as the body corporate or partnership) commitsthe offence and is liable to be proceeded against and punished accordingly.\n\t\tIn relation to a body corporate, \u201cofficer\u201d means\u2014\n\t\t\ta director, manager, secretary or other similar officer of the body, or\n\t\t\ta person purporting to act in any such capacity.\n\t\tIn subsection (2)(a), \u201cdirector\u201d, in relation to a body corporate whoseaffairs are managed by its members, means a member of the body corporate.\n\t\tIn relation to a Scottish partnership, \u201cofficer\u201d means\u2014\n\t\t\ta partner, or\n\t\t\ta person purporting to act as a partner."
    },
    {
        "length": 799,
        "text": "\nForfeiture\n\tForfeiture of medical devices\n\t\tThe enforcement authority may apply to the appropriate lower court (seesection 42) for an order for the forfeiture of a medical device (a \u201cforfeitureorder\u201d) on the grounds that there has been a contravention of a medicaldevices provision in relation to the device.\n\t\tThe appropriate lower court may make a forfeiture order if satisfied thatthere has been such a contravention.\n\t\tThe enforcement authority must make reasonable efforts to give notice ofthe application to every person who the enforcement authority thinks is or maybe entitled to the device to which the application relates.\n\t\tEach person claiming to be entitled to the device may\u2014\n\t\t\tappear at the hearing of the application, or\n\t\t\tmake written representations to the appropriate lower court in relation tothe application.\n\t\tIf the appropriate lower court decides to make a forfeiture order, thecourt may include in the order provision that the device to which the orderrelates is not to be forfeited before the appropriate time.\n\t\tThe enforcement authority may dispose of a forfeited device in whatever waythe enforcement authority thinks appropriate.\n\t\tBut the enforcement authority may not dispose of a forfeited device beforethe appropriate time.\n\t\tIn this section, the \u201cappropriate time\u201d is\u2014\n\t\t\tthe end of the period within which an appeal under section 33 may be madeagainst the order, or\n\t\t\tif such an appeal is made, the end of the day on which the appeal isfinally determined or otherwise disposed of.\n\t\tIn this section, persons \u201centitled to a device\u201d are\u2014\n\t\t\tif the device has not been seized by the enforcement authority, the personin possession of the device,\n\t\t\tif the device has been seized, the person from whom it was seized, or\n\t\t\tif different, any person to whom it belongs.\n\tAppeals against forfeiture decisions\n\t\tA person claiming to be entitled to a medical device which is subject to aforfeiture order may appeal against the decision to make the order.\n\t\tThe enforcement authority may appeal against a decision of the appropriatelower court to refuse an application for a forfeiture order.\n\t\tAn appeal under this section is to the appropriate appeals court (seesection 42).\n\t\tAn appeal under this section must be made before the end of the period of28 days beginning with the day on which\u2014\n\t\t\tthe forfeiture order is made, or\n\t\t\tthe application for a forfeiture order is refused.\n\t\tSubject to subsection (6), the court hearing the appeal may make any orderthe court thinks appropriate.\n\t\tIf an appeal against a decision to make a forfeiture order is allowed, thecourt must, if the device to which the order relates has already beenforfeited, order it to be returned to a person entitled to it.\n\t\tIn this section, persons \u201centitled to a device\u201d are\u2014\n\t\t\tif the device has not been seized by the enforcement authority, the personin possession of the device,\n\t\t\tif the device has been seized, the person from whom it was seized, or\n\t\t\tif different, any person to whom it belongs."
    },
    {
        "length": 294,
        "text": "\nRecovery of expenses of enforcement\n\tRecovery of expenses of enforcement\n\t\tThis section applies where a court\u2014\n\t\t\tconvicts a person of an offence under section 28 or regulation 60A of theMedical Devices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain\"Go to item of legislation\")) (offence of breaching certain provisions in theRegulations) in relation to a medical device, or\n\t\t\tmakes a forfeiture order under section 32 or 33(5) in relation to a medicaldevice.\n\t\tThe court may (in addition to any other order it may make as to costs orexpenses) order the person convicted or, as the case may be, a person fromwhom a device is seized or to whom it belongs to reimburse an enforcementauthority for any expenditure which the authority has incurred or may incur\u2014\n\t\t\tin connection with any seizure or detention of the device by or on behalfof the authority, or\n\t\t\tin connection with giving effect to the forfeiture order."
    },
    {
        "length": 207,
        "text": "\nRecall of medical device by enforcement authority\n\tRecall of medical device by enforcement authority\n\t\tThis section applies where the enforcement authority considers that\u2014\n\t\t\tit is necessary to restrict the availability of a medical device in orderto protect health or safety, and\n\t\t\tthe device has already been supplied or made available to members of thepublic.\n\t\tThe authority may take such steps as it considers necessary to organise thereturn of the device to the authority or to another person (whether or not itissues a safety notice under section 23 requiring another person to organiseor cooperate in organising the recall of the device).\n\t\tThe authority may take steps in reliance on subsection (2) only ifsatisfied that no alternative steps that did not involve recalling the devicewould sufficiently protect health or safety as mentioned in subsection (1)."
    },
    {
        "length": 510,
        "text": "\nPower of officer of Revenue and Customs to detain medical device\n\tPower of officer of Revenue and Customs to detain medical device\n\t\tAn officer of Revenue and Customs may seize an imported medical device anddetain it for not more than two working days in order to facilitate theexercise by an enforcement authority or an officer of an enforcement authorityof a function under\u2014\n\t\t\tthis Part,\n\t\t\ta medical devices provision, or\n\t\t\tSchedule 5 to the Consumer Rights Act 2015.\n\t\tA device seized and detained under this section must be dealt with duringthe period of its detention in such manner as the Commissioners for HerMajesty\u2019s Revenue and Customs may direct.\n\t\tIn subsection (1), the reference to two working days is a reference to aperiod of 48 hours calculated from the time when the device in question isseized but disregarding so much of any period as falls on a Saturday or Sundayor on Christmas Day, Good Friday or a day which is a bank holiday under theBanking and Financial Dealings Act 1971 in the part of the United Kingdomwhere the device is seized.\n\tOffence of obstructing an officer of Revenue and Customs\n\t\tA person commits an offence if the person intentionally obstructs anofficer of Revenue and Customs who is acting under section 36.\n\t\tA person guilty of an offence under subsection (1) is liable\u2014\n\t\t\ton summary conviction in England and Wales, to imprisonment for a term notexceeding 51 weeks, to a fine or to both;\n\t\t\ton summary conviction in Scotland or Northern Ireland, to imprisonment fora term not exceeding 6 months, to a fine not exceeding level 5 on the standardscale or to both.\n\t\tIn relation to an offence committed before the coming into force of section281(5) of the Criminal Justice Act 2003, the reference in subsection (2)(a) to51 weeks is to be read as a reference to 6 months."
    },
    {
        "length": 147,
        "text": "\nCivil proceedings\n\tCivil proceedings\n\t\tAn obligation imposed by a medical devices provision is to be treated as aduty owed to any person who may be affected by a breach of the obligation.\n\t\tAccordingly, a breach of such an obligation gives rise to a right of actionfor breach of statutory duty.\n\t\tSubsections (1) and (2) are subject to\u2014\n\t\t\ta provision to the contrary in a medical devices provision, and\n\t\t\tthe defences and other incidents applying to actions for breach ofstatutory duty."
    },
    {
        "length": 2714,
        "text": "\nCHAPTER 4Disclosure of information and consequential etc provision\n\tDisclosure of information\n\t\tDisclosure of information\n\t\t\tThis section applies in relation to information which the Secretary ofState holds in connection with medical devices.\n\t\t\tThe Secretary of State may disclose information for the purpose of warningmembers of the public about concerns that the Secretary of State has inrelation to the safety of a medical device.\n\t\t\tThe Secretary of State may disclose information to a person who providesservices or exercises functions relating to medical devices for the purposesof\u2014\n\t\t\t\tenabling or facilitating the exercise by the Secretary of State of afunction relating to medical devices;\n\t\t\t\tenabling or facilitating the exercise by another person of a functionrelating to medical devices;\n\t\t\t\tenabling or facilitating the provision of a service relating to medicaldevices by another person.\n\t\t\tThe Secretary of State may disclose information for the purposes of\u2014\n\t\t\t\tcivil proceedings;\n\t\t\t\tcriminal investigations or proceedings.\n\t\t\tThe Secretary of State may disclose information to a relevant personoutside the United Kingdom where\u2014\n\t\t\t\tthe disclosure is required for the purpose of giving effect to aninternational agreement or arrangement concerning the regulation of medicaldevices, and\n\t\t\t\tthe Secretary of State considers that the disclosure is in the publicinterest.\n\t\t\tBut subsection (5) does not authorise a disclosure of patient informationwithout the consent of the individual to whom that information relates.\n\t\t\tThe Secretary of State may not disclose commercially sensitive informationin reliance on subsection (2), (3), (4) or (5) unless the Secretary of State\u2014\n\t\t\t\tconsiders that it is necessary to do so for one or more of the purposesmentioned in subsection (2), (3), (4) or (5), and\n\t\t\t\tis satisfied that the making of the disclosure is proportionate to what issought to be achieved by it.\n\t\t\tWhere information to which this section applies is disclosed to a person inreliance on subsection (3) or (4), the person may not use or further disclosethe information except\u2014\n\t\t\t\twith the agreement of the Secretary of State and for a purpose mentioned insubsection (3) or (4), or\n\t\t\t\tin accordance with an enactment or order of a court or tribunal.\n\t\t\tExcept as provided by subsection (10), the disclosure of information inaccordance with this section does not breach\u2014\n\t\t\t\tan obligation of confidence owed by the person making the disclosure, or\n\t\t\t\tany other restriction on the disclosure of the information (howeverimposed).\n\t\t\tNothing in this section authorises a disclosure of information which\u2014\n\t\t\t\tcontravenes the data protection legislation (but in determining whether adisclosure would do so, take into account the powers conferred by thissection), or\n\t\t\t\tis prohibited by any of Parts 1 to 7 or Chapter 1 of Part 9 of theInvestigatory Powers Act 2016.\n\t\t\tThis section does not limit the circumstances in which information may bedisclosed under any other enactment or rule of law.\n\t\t\tIn this section\u2014\n\t\t\t\t  * \u201ccommercially sensitive information\u201d means commercial information whose disclosure the Secretary of State thinks might significantly harm the legitimate business interests of the undertaking to which it relates; \n\t\t\t\t  * \u201cpatient information\u201d means information (however recorded) which\u2014 \n\t\t\t\trelates to\u2014\n\t\t\t\tthe physical or mental health or condition of an individual,\n\t\t\t\tthe diagnosis of an individual\u2019s condition, or\n\t\t\t\tan individual\u2019s care or treatment,\n\t\t\t\t\tor is (to any extent) derived directly or indirectly from information relatingto any of those matters, and\n\t\t\t\tidentifies the individual or enables the individual to be identified (whetherby itself or in combination with other information);\n\t\t\t\t\t  * \u201crelevant person\u201d means\u2014 \n\t\t\t\tthe government of a country or territory outside the United Kingdom;\n\t\t\t\ta person who exercises functions on behalf of such a government;\n\t\t\t\tany other person who exercises functions or provides services relating tomedical devices in a country or territory outside the United Kingdom;\n\t\t\t\tan international organisation that exercises functions or provides servicesrelating to medical devices.\n\t\tOffences relating to information\n\t\t\tA person to whom information is disclosed under section 39 commits anoffence if the person uses or discloses that information in contravention ofsubsection (8) of that section.\n\t\t\tA person to whom information is disclosed under regulations under section19 (information systems) commits an offence if the person uses or disclosesthat information in contravention of those regulations.\n\t\t\tA person guilty of an offence under subsection (1) or (2) is liable\u2014\n\t\t\t\ton summary conviction in England and Wales, to imprisonment for a term notexceeding 51 weeks, to a fine or to both;\n\t\t\t\ton summary conviction in Scotland or Northern Ireland, to imprisonment fora term not exceeding 6 months, to a fine not exceeding level 5 on the standardscale or to both.\n\t\t\tIn relation to an offence committed before the coming into force of section281(5) of the Criminal Justice Act 2003, the reference in subsection (3)(a) to51 weeks is to be read as a reference to 6 months.\n\tConsequential etc provision\n\t\tConsequential and supplementary provision\n\t\t\tIn the Consumer Protection Act 1987\u2014\n\t\t\t\tin section 11 (safety regulations), in subsection (7), at the end insert\u2014\n\t\t\t\tmedical devices.\u201d;\n\t\t\t\tin section 19 (interpretation of Part 2), in subsection (1), at theappropriate place insert\u2014\n\t\t\t\t\t  * \u201c\u201cmedical device\u201d has the same meaning as in Part 4 of the Medicines and Medical Devices Act 2021;\u201d.\n\t\t\tIn the Consumer Rights Act 2015, in Schedule 5 (investigatory powers etc)\u2014\n\t\t\t\tin paragraph 10 (enforcer\u2019s legislation: duties and powers mentioned inparagraph 9(1)(a)), at the appropriate place insert \u201cregulation 61 of theMedical Devices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain\"Go to item of legislation\"))\u201d;\n\t\t\t\tin the table in paragraph 11 (enforcer\u2019s legislation), at the end insert\u2014\n\t\t\t\t\t\u201cThe Secretary of State, a local weights and measures authority in GreatBritain or a district council in Northern Ireland| Regulations made undersection 15(1) of the Medicines and Medical Devices Act 2021  ---|---  The Secretary of State, a local weights and measures authority in GreatBritain or a district council in Northern Ireland| Chapter 3 of Part 4 of theMedicines and Medical Devices Act 2021\u201d;    (c)in paragraph 19 (exercise of powers in Part 4), after sub-paragraph (7)insert\u2014\n\t\t\t\t\u201c(7A)A domestic enforcer may exercise the power in paragraph 30A (power todecommission or switch off fixed medical devices)\u2014\n\t\t\t\tif an officer of the enforcer reasonably suspects a breach of the MedicalDevices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain \"Go toitem of legislation\")) or of regulations made under section 15(1) of theMedicines and Medical Devices Act 2021, and\n\t\t\t\tfor the purpose of ascertaining (by means of testing or otherwise) whetherthere has been such a breach.\u201d;\n\t\t\t\tafter paragraph 30 insert\u2014\n\t\t\t\t\u201c30A(1)The power in sub-paragraph (2) is available to an officer of a domesticenforcer acting pursuant to the duty in regulation 61(1A) or (1B) of theMedical Devices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain\"Go to item of legislation\")) or to a duty in regulations made under section15(1) of the Medicines and Medical Devices Act 2021.\n\t\t\tThe officer may decommission or switch off any medical device to which theMedical Devices Regulations 2002 apply which is installed at a givenlocation.\u201d;\n\t\t\t\tin paragraph 31 (power to break open container etc)\u2014\n\t\t\t\tin sub-paragraph (1), for \u201c30\u201d substitute \u201c30A\u201d;\n\t\t\t\tin sub-paragraph (2), for \u201c30\u201d substitute \u201c30A\u201d.\n\t\t\tThe Medical Devices Regulations 2002 ([S.I.2002/618](/id/uksi/2002/618?view=plain \"Go to item of legislation\")) areamended in accordance with subsections (4) to (7).\n\t\t\tIn regulation 2 (interpretation), in paragraph (1) omit the definition of\u201cthe 1987 Act\u201d.\n\t\t\tOmit regulation 3B (confidentiality).\n\t\t\tIn regulation 61 (enforcement and the Consumer Protection Act 1987 etc),for paragraphs (1) to (8) substitute\u2014\n\t\t\t\u201c(1A)It is the duty of the Secretary of State to enforce these regulations inrelation to relevant devices and devices for performance evaluation.\n\t\t\t(1B)It is the duty of each weights and measures authority in Great Britain andeach district council in Northern Ireland to enforce these regulations withinits area (concurrently with the Secretary of State) in relation to relevantdevices that are ordinarily intended for private use or consumption.\n\t\t\t(1C)Nothing in this regulation authorises a weights and measures authority tobring proceedings in Scotland for an offence.\u201d\n\t\t\tOmit\u2014 \n\t\t\t\tregulation 62 (compliance notices),\n\t\t\t\tregulation 63 (restriction notices), and\n\t\t\t\tregulation 64 (notification of decisions etc).\n\t\t\tAs a result of the amendments made by subsections (1), (4), (6) and (7),the Medical Devices Regulations 2002 are not to be recognised as safetyregulations for the purposes of the Consumer Protection Act 1987, but thoseamendments do not otherwise affect the continued operation of thoseregulations.\n\t\t\tSchedule 3 makes it an offence to breach various provisions in the MedicalDevices Regulations 2002."
    },
    {
        "length": 1154,
        "text": "\nCHAPTER 5Interpretation of Part 4\n\tInterpretation of Part 4\n\t\tIn this Part, apart from in sections 32, 33 and 34 (provisions relating toforfeiture or seizure of medical devices), references to a medical deviceinclude references to a type of medical device.\n\t\tIn this Part\u2014\n\t\t\t  * the \u201cappropriate appeals court\u201d means\u2014 \n\t\t\tin England and Wales, the Crown Court;\n\t\t\tin Scotland, the Sheriff Appeal Court;\n\t\t\tin Northern Ireland, a county court;\n\t\t\t\t  * the \u201cappropriate lower court\u201d means\u2014 \n\t\t\tin England and Wales, a magistrates\u2019 court;\n\t\t\tin Scotland, the sheriff;\n\t\t\tin Northern Ireland, a court of summary jurisdiction;\n\t\t\t\t  * \u201ccompliance notice\u201d has the meaning given by section 21(2); \n\t\t\t\t  * \u201cdata protection legislation\u201d has the meaning given by section 3(9) of the Data Protection Act 2018; \n\t\t\t\t  * the \u201cenforcement authority\u201d means\u2014 \n\t\t\tin relation to medical devices which are ordinarily intended for private useor consumption\u2014\n\t\t\ta local weights and measures authority in Great Britain or a district councilin Northern Ireland, or\n\t\t\tthe Secretary of State, or\n\t\t\tin relation to other medical devices, the Secretary of State;\n\t\t\t\t  * \u201cEU Medical Devices Regulations\u201d means\u2014 \n\t\t\t[Regulation (EU) 2017/745](/european/regulation/2017/0745?view=plain \"Go toitem of legislation\") of the European Parliament and of the Council of 5 April2017 on medical devices, amending [Directive2001/83/EC](/european/directive/2001/0083?view=plain \"Go to item oflegislation\"), Regulation [(EC) No178/2002](/european/regulation/2002/0178?view=plain \"Go to item oflegislation\") and Regulation [(EC) No1223/2009](/european/regulation/2009/1223?view=plain \"Go to item oflegislation\") and repealing Council [Directives90/385/EEC](/european/directive/1990/0385?view=plain \"Go to item oflegislation\") and [93/42/EEC](/european/directive/1993/0042?view=plain \"Go toitem of legislation\"), and\n\t\t\t[Regulation (EU) 2017/746](/european/regulation/2017/0748?view=plain \"Go toitem of legislation\") of the European Parliament and of the Council of 5 April2017 on in vitro diagnostic medical devices and repealing [Directive98/79/EC](/european/directive/1998/0079?view=plain \"Go to item oflegislation\") and [Commission Decision2010/227/EU](/european/decision/2010/0227?view=plain \"Go to item oflegislation\");\n\t\t\t\t  * \u201cforfeiture order\u201d has the meaning given by section 32(1); \n\t\t\t\t  * \u201cinformation notice\u201d has the meaning given by section 24(2); \n\t\t\t\t  * \u201cmanufacture\u201d includes assembly; \n\t\t\t\t  * \u201cmanufacturer\u201d means any person who is a manufacturer for the purposes of any provision in the Medical Devices Regulations 2002 ([S.I. 2002/618](/id/uksi/2002/618?view=plain \"Go to item of legislation\")); \n\t\t\t\t  * \u201cmedical device\u201d includes\u2014 \n\t\t\tmedical devices to which the Medical Devices Regulations 2002 apply, and\n\t\t\tdevices to which the EU Medical Devices Regulations apply;\n\t\t\t\t  * \u201cmedical devices provision\u201d has the meaning given by section 17(2); \n\t\t\t\t  * \u201crelevant requirements\u201d has the meaning given by section 16(1)(a); \n\t\t\t\t  * \u201csafety notice\u201d has the meaning given by section 23(1); \n\t\t\t\t  * \u201csuspension notice\u201d has the meaning given by section 22(2). "
    },
    {
        "length": 2642,
        "text": "\nPART 5Regulations under Parts 1, 2, 3 and 4\n\tPower to make consequential etc provision\n\t\tThis section applies to regulations under a power in Part 1, 2, 3 or 4,apart from regulations under paragraph 9 of Schedule 2.\n\t\tThe regulations may\u2014\n\t\t\tmake consequential, supplementary, incidental, transitional, transitory orsaving provision;\n\t\t\tmake different provision for different purposes;\n\t\t\tmake different provision for different areas;\n\t\t\tmake provision for all cases to which the power applies or for those casessubject to specified exceptions or for any specified cases or descriptions ofcase.\n\tScope of powers of Northern Ireland departments\n\t\tNo provision may be made by a Northern Ireland department acting alone inregulations under section 2(1) or 10(1) unless the provision, if it werecontained in an Act of the Northern Ireland Assembly\u2014\n\t\t\twould be within the legislative competence of the Assembly, and\n\t\t\twould not require the consent of the Secretary of State.\n\tConsultation \n\t\tBefore making regulations under a provision of Part 1, 2, 3 or 4, therelevant authority must carry out a public consultation.\n\t\tIn relation to proposed regulations under section 19(1), the Secretary ofState must specifically consult\u2014\n\t\t\tthe Welsh Ministers,\n\t\t\tthe Scottish Ministers, and\n\t\t\tthe Department of Health in Northern Ireland.\n\t\tIn relation to proposed regulations under section 2(1), 10(1) or 15(1), theconsultation document must include a summary of the relevant authority\u2019sassessment of the matters mentioned in section 2, 10 or 15 (as the case maybe).\n\t\tThe duty to consult imposed by subsection (1) does not apply in relation toregulations that contain only provision made in reliance on\u2014\n\t\t\tsection 7 (disapplication of provisions relating to human medicines wherethere is a risk of serious harm to health), or\n\t\t\tsection 18 (disapplication of provisions relating to medical devices wherethere is a risk of serious harm to health),\n\t\t\t\twhere the regulations contain a declaration that the person making themconsiders that they need to be made urgently to protect the public from animminent risk of serious harm to health.\n\t\tThe duty to consult imposed by subsection (1) may be satisfied byconsultation carried out before this Act was passed.\n\t\tIn this section, \u201cthe relevant authority\u201d means\u2014\n\t\t\tin relation to regulations made under section 2(1) or 10(1), theappropriate authority within the meaning given by section 2(6) or 10(6) as thecase may be, and\n\t\t\tin relation to any other regulations, the Secretary of State.\n\tReporting requirements\n\t\tAs soon as reasonably practicable after the end of each reporting period,the relevant authority must lay before the appropriate legislature a report onthe operation of any regulations made by the relevant authority under sections2(1), 10(1), 15(1) and 19(1) that were in force at any time during thereporting period.\n\t\tIn preparing a report, the relevant authority must consult such persons asthe relevant authority considers appropriate.\n\t\tA report must include a summary of\u2014\n\t\t\tany concerns raised, or proposals for change made, by a person consulted inaccordance with subsection (2), and\n\t\t\tthe relevant authority\u2019s response to those concerns or proposals, includingany plan the relevant authority may have to make further regulations undersection 2(1), 10(1), 15(1) or 19(1).\n\t\tThe reporting periods are\u2014\n\t\t\tthe period of 24 months beginning with the day on which the first set ofregulations under section 2(1), 10(1), 15(1) or 19(1) comes into force, and\n\t\t\teach successive period of 24 months.\n\t\tIn this section\u2014\n\t\t\t  * \u201cappropriate legislature\u201d means\u2014 \n\t\t\tin relation to a report of the Secretary of State, Parliament;\n\t\t\tin relation to a report of a Northern Ireland department, the Northern IrelandAssembly;\n\t\t\t\t  * \u201crelevant authority\u201d means\u2014 \n\t\t\tin relation to regulations made under section 2(1) or 10(1) by the Secretaryof State (whether acting alone or jointly with a Northern Ireland department),the Secretary of State;\n\t\t\tin relation to regulations made under section 2(1) or 10(1) by a NorthernIreland department (whether acting alone or jointly with the Secretary ofState), the Northern Ireland department;\n\t\t\tin relation to regulations made under section 15(1) or 19(1), the Secretary ofState.\n\tProcedure \n\t\tAny power to make regulations under a provision of Part 1, 2, 3 or 4 so faras exercisable by the Secretary of State, or by the Secretary of State actingjointly with a Northern Ireland department, is exercisable by statutoryinstrument.\n\t\tAny power to make regulations under section 2(1) or 10(1) so far asexercisable by a Northern Ireland department (other than when acting jointlywith the Secretary of State) is exercisable by statutory rule for the purposesof the Statutory Rules (Northern Ireland) Order 1979 ([S.I. 1979/1573 (N.I.12)](/id/nisi/1979/1573?view=plain \"Go to item of legislation\")) (and not bystatutory instrument).\n\t\tThe procedure for making regulations under Part 1, 2, 3 or 4 is to bedetermined in accordance with this table and subsection (4)\u2014\n\t\t\tIf the regulations contain provision made in reliance on| the regulations aresubject to  ---|---  section 6(1)(a)| the negative procedure  section 12(1)(a)| the negative procedure  section 17(1)(a)| the negative procedure  paragraph 9 of Schedule 2| the negative procedure  section 7|\n\t\t\tthe made affirmative procedure, where the regulations contain a declarationthat the person making them considers that they need to be made urgently toprotect the public from an imminent risk of serious harm to health\n\t\t\tthe draft affirmative procedure in any other case    section 18|\n\t\t\tthe made affirmative procedure, where the regulations contain a declarationthat the person making them considers that they need to be made urgently toprotect the public from an imminent risk of serious harm to health\n\t\t\tthe draft affirmative procedure in any other case    any other provision of Part 1, 2, 3 or 4| the draft affirmative procedure    (4)Provision that may be made by regulations subject to the negative proceduremay be made by regulations subject to the draft affirmative procedure.\n\t\tWhere regulations are subject to \u201cthe negative procedure\u201d\u2014\n\t\t\tin the case of regulations made by the Secretary of State acting alone, thestatutory instrument containing the regulations is subject to annulment inpursuance of a resolution of either House of Parliament,\n\t\t\tin the case of regulations made by a Northern Ireland department actingalone, they are subject to negative resolution within the meaning given bysection 41(6) of the Interpretation Act (Northern Ireland) 1954, and\n\t\t\tin the case of regulations made by the Secretary of State and a NorthernIreland department acting jointly, the statutory instrument containing theregulations is subject to\u2014\n\t\t\tannulment in pursuance of a resolution of either House of Parliament, and\n\t\t\tnegative resolution within the meaning given by section 41(6) of theInterpretation Act (Northern Ireland) 1954.\n\t\tWhere regulations are subject to the \u201cdraft affirmative procedure\u201d\u2014\n\t\t\tin the case of regulations made by the Secretary of State acting alone, thestatutory instrument containing the regulations may not be made unless a draftof the instrument has been laid before and approved by a resolution of eachHouse of Parliament,\n\t\t\tin the case of regulations made by a Northern Ireland department actingalone, they may not be made unless a draft of the regulations has been laidbefore and approved by a resolution of the Northern Ireland Assembly, and\n\t\t\tin the case of regulations made by the Secretary of State and a NorthernIreland department acting jointly, the statutory instrument containing theregulations may not be made unless a draft of the instrument has been laidbefore and approved by a resolution of\u2014\n\t\t\teach House of Parliament, and\n\t\t\tthe Northern Ireland Assembly.\n\t\tWhere regulations are subject to the \u201cmade affirmative procedure\u201d\u2014\n\t\t\tin the case of regulations made by the Secretary of State acting alone, thestatutory instrument containing the regulations\u2014\n\t\t\tmust be laid before Parliament after being made, and\n\t\t\tceases to have effect at the end of the period of 40 days beginning withthe day on which the instrument is made unless, during that period, theinstrument is approved by a resolution of each House of Parliament,\n\t\t\tin the case of regulations made by a Northern Ireland department actingalone, they\u2014\n\t\t\tmust be laid before the Northern Ireland Assembly after being made, and\n\t\t\tcease to have effect at the end of the period of 40 days beginning withthe day on which they are made unless, during that period, the regulations areapproved by a resolution of the Assembly, and\n\t\t\tin the case of regulations made by the Secretary of State and a NorthernIreland department acting jointly, the statutory instrument containing theregulations\u2014\n\t\t\tmust be laid before Parliament and the Northern Ireland Assembly afterbeing made, and\n\t\t\tceases to have effect at the end of the period of 40 days beginning withthe day on which the instrument is made unless, during that period, theinstrument is approved by a resolution of each House of Parliament and by aresolution of the Assembly.\n\t\tIn calculating the period of 40 days for the purposes of subsection(7)(a)(ii) or (c)(ii) in relation to Parliament, no account is to be taken ofany time during which\u2014\n\t\t\tParliament is dissolved or prorogued, or\n\t\t\teither House of Parliament is adjourned for more than 4 days.\n\t\tIn calculating the period of 40 days for the purposes of subsection(7)(b)(ii) or (c)(ii) in relation to the Northern Ireland Assembly, no accountis to be taken of any time during which the Assembly is\u2014\n\t\t\tdissolved, \n\t\t\tin recess for more than 4 days, or\n\t\t\tadjourned for more than 6 days.\n\t\tIf regulations cease to have effect as a result of subsection (7) that\u2014\n\t\t\tdoes not affect the validity of anything previously done under theregulations, and\n\t\t\tdoes not prevent the making of new regulations."
    },
    {
        "length": 461,
        "text": "\nPART 6Report on operation of medicines and medical devices legislation\n\tReport on operation of medicines and medical devices legislation\n\t\tThe Secretary of State must, before the end of the relevant period, publisha report on the operation of medicines and medical devices legislation.\n\t\tThe report must, in particular, include an assessment of whether\u2014\n\t\t\tsome or all medicines and medical devices legislation should beconsolidated or otherwise restructured,\n\t\t\tprovisions of medicines and medical devices legislation should be includedin regulations or Acts of Parliament, and\n\t\t\tpowers to make regulations should be modified or repealed.\n\t\tIn preparing the report, the Secretary of State must take into account anyreport relating to the operation of medicines and medical devices legislationmade by a Parliamentary Committee.\n\t\tThe Secretary of State must lay a copy of the report before Parliament.\n\t\tIn this section\u2014\n\t\t\t  * \u201cmedicines and medical devices legislation\u201d means\u2014 \n\t\t\tthe law relating to human medicines within the meaning of section 9(interpretation);\n\t\t\tthe Veterinary Medicines Regulations 2013 ([S.I.2013/2033](/id/uksi/2013/2033?view=plain \"Go to item of legislation\"));\n\t\t\tthe Medical Devices Regulations 2002 ([S.I.2002/618](/id/uksi/2002/618?view=plain \"Go to item of legislation\"));\n\t\t\tParts 2 to 5 of this Act;\n\t\t\tregulations made under those Parts;\n\t\t\t\t  * \u201cParliamentary Committee\u201d means a committee of the House of Commons or of the House of Lords or a joint committee of both Houses; \n\t\t\t\t  * \u201crelevant period\u201d means the period of 5 years beginning with the day on which this Act is passed. "
    },
    {
        "length": 788,
        "text": "\nPART 7Extent, commencement and short title\n\tExtent \n\t\tThis Act extends to England and Wales, Scotland and Northern Ireland.\n\tCommencement \n\t\tThe following come into force on the day on which this Act is passed\u2014\n\t\t\tthis Part,\n\t\t\tsection 2,\n\t\t\tsection 6(4),\n\t\t\tsection 7,\n\t\t\tsection 9,\n\t\t\tsection 15,\n\t\t\tsection 17(2),\n\t\t\tsection 18,\n\t\t\tsection 42,\n\t\t\tPart 5, and\n\t\t\tPart 6.\n\t\tThe following come into force at the end of the period of two monthsbeginning with the day on which this Act is passed\u2014\n\t\t\tPart 1,\n\t\t\tthe remaining provisions of Part 2,\n\t\t\tPart 3,\n\t\t\tthe remaining provisions of Chapter 1 of Part 4, and\n\t\t\tChapter 2 of Part 4.\n\t\tChapters 3 and 4 of Part 4 (medical devices: enforcement and disclosure ofinformation) come into force on such day or days as the Secretary of State mayby regulations made by statutory instrument appoint.\n\t\tRegulations may not be made in reliance on section 7 or 18 that come intoforce before the end of the period of two months beginning with the day onwhich this Act is passed unless they contain a declaration that the personmaking them considers that they need to be made urgently to protect the publicfrom an imminent risk of serious harm to health.\n\tTransitional etc provision in connection with commencement\n\t\tThe Secretary of State may by regulations made by statutory instrument maketransitional, transitory or saving provision in connection with the cominginto force of any provision of this Act (subject to subsection (4)).\n\t\tThe relevant Northern Ireland department may by regulations maketransitional, transitory or saving provision in connection with the cominginto force of Part 2 or, as the case may be, Part 3 so far as relating toNorthern Ireland.\n\t\tNo provision may be made by the relevant Northern Ireland department inregulations under subsection (2) unless the provision, if it were contained inan Act of the Northern Ireland Assembly\u2014\n\t\t\twould be within the legislative competence of the Assembly, and\n\t\t\twould not require the consent of the Secretary of State.\n\t\tRegulations of the Secretary of State under this section may not containprovision that could be made by regulations of the relevant Northern Irelanddepartment under this section.\n\t\tThe power to make regulations under subsection (2) is exercisable bystatutory rule for the purposes of the Statutory Rules (Northern Ireland)Order 1979 ([S.I. 1979/1573 (N.I. 12)](/id/nisi/1979/1573?view=plain \"Go toitem of legislation\")).\n\t\tIn this section, the \u201crelevant Northern Ireland department\u201d means\u2014\n\t\t\tin relation to Part 2, the Department of Health in Northern Ireland, and\n\t\t\tin relation to Part 3, the Department of Agriculture, Environment and RuralAffairs in Northern Ireland.\n\tShort title\n\t\tThis Act may be cited as the Medicines and Medical Devices Act 2021."
    }
]